Seres Therapeutics, Inc. (MCRB) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Seres Therapeutics, Inc. (MCRB) closed at USD 2.42 on 2026-10-14, a change of -85.9 % over the past year, with a market capitalization of USD 25.41M.

Seres Therapeutics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Seres Therapeutics, Inc. key figures

Previous close

USD 2.42 (2026-10-14)

1-year change

-85.9 %

Market cap

USD 25.41M

Enterprise value

USD 66.2M

P/E ratio (trailing)

-1.05

P/E ratio (forward)

-0.51

EPS (trailing)

-2.42

EPS (forward)

-4.95

PEG ratio

n/a

Price to book

0.72

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.53

Employees

66

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Seres Therapeutics, Inc.

Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. It also develops SER-603, a LBP candidate optimized to treat disruptions in the GI microbiome and to improve GI mucosal barrier integrity through the inhibition of inflammatory bacteria and associated metabolites; and SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Seres Therapeutics, Inc. and compare it with other stocks.